Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
Study NCT ID:
NCT01035502
Status:
COMPLETED
Last Update Posted:
2013-09-27
First Post:
2009-12-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia
Sponsor:
Clavis Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2013-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-15
First Submit QC Date:
None
Study First Post Date:
2009-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-09-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-09-20
Last Update Post Date:
2013-09-27
Last Update Post Date Type:
ESTIMATED